Pulmicort Asthma Prevention (Post-PAC)
Study identifier:D5254C00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A study to evaluate the feasibility of a treatment algorithm in newly diagnosed asthmatic children. An open follow-up to Asthma Prevention in infants/young children (PAC)
Medical condition
asthma
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
400
Study type
Interventional
Age
0 Months - 6 Years
Date
Study Start Date: 01 Jul 2001
Primary Completion Date: 01 May 2006
Study Completion Date: 01 Jun 2006
Study design
Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Jan 2008 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Denmark Medical Director
AstraZeneca
